Chemoinformaics analysis of SCUTELLAREIN 6-XYLOSIDE
| Molecular Weight | 418.354 | nRot | 3 |
| Heavy Atom Molecular Weight | 400.21 | nRig | 24 |
| Exact Molecular Weight | 418.09 | nRing | 4 |
| Solubility: LogS | -3.878 | nHRing | 2 |
| Solubility: LogP | 0.775 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 48 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 30 | No. of Aromatic Carbocycles | 2 |
| nHetero | 10 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 10 | No. of Arom Bond | 17 |
| nHA | 10 | APOL | 53.4223 |
| nHD | 6 | BPOL | 24.1337 |
| QED | 0.35 |
| Synth | 3.875 |
| Natural Product Likeliness | 1.923 |
| NR-PPAR-gamma | 0.957 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.004 |
| Pgp-sub | 0.922 |
| HIA | 0.737 |
| CACO-2 | -5.92 |
| MDCK | 0.00000571 |
| BBB | 0.028 |
| PPB | 0.912039 |
| VDSS | 0.831 |
| FU | 0.100552 |
| CYP1A2-inh | 0.077 |
| CYP1A2-sub | 0.053 |
| CYP2c19-inh | 0.023 |
| CYP2c19-sub | 0.056 |
| CYP2c9-inh | 0.023 |
| CYP2c9-sub | 0.493 |
| CYP2d6-inh | 0.037 |
| CYP2d6-sub | 0.187 |
| CYP3a4-inh | 0.044 |
| CYP3a4-sub | 0.028 |
| CL | 2.377 |
| T12 | 0.563 |
| hERG | 0.073 |
| Ames | 0.676 |
| ROA | 0.055 |
| SkinSen | 0.368 |
| Carcinogencity | 0.32 |
| EI | 0.069 |
| Respiratory | 0.052 |
| NR-Aromatase | 0.915 |
| Antiviral | Yes |
| Prediction | 0.920827 |